Published in J Exp Anal Behav on November 01, 1968
Response strength in multiple schedules. J Exp Anal Behav (1974) 9.07
Choice for periodic schedules of reinforcement. J Exp Anal Behav (1970) 5.56
On the form of the relation between response rates in a multiple schedule. J Exp Anal Behav (1974) 4.17
A response duration schedule: effects of training, extinction, and deprivation. J Exp Anal Behav (1970) 1.60
Economics, ecologics, and mechanics: The dynamics of responding under conditions of varying motivation. J Exp Anal Behav (1995) 1.30
Resistance to change produced by access to fixed-delay versus variable-delay terminal links. J Exp Anal Behav (1986) 1.18
Response strength in multiple periodic and aperiodic schedules. J Exp Anal Behav (1980) 1.13
Responding on concurrent-chains schedules in open and closed economies. J Exp Anal Behav (1989) 0.94
Analysis of factors that affect responding in a two-response chain in children with developmental disabilities. J Appl Behav Anal (2006) 0.85
Do establishing operations alter reinforcement effectiveness? Behav Anal (1993) 0.81
A review of positive conditioned reinforcement. J Exp Anal Behav (1962) 24.28
An experimental outline for building and exploring multi-operant behavior repertoires. J Exp Anal Behav (1962) 16.78
Effects of required rates of responding upon choice. J Exp Anal Behav (1968) 6.58
A quantitative comparison of the discriminative and reinforcing functions of a stimulus. J Exp Psychol (1950) 3.94
Choice and rate of reinforcement. J Exp Anal Behav (1969) 14.75
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Preference for mixed- versus fixed-ratio schedules. J Exp Anal Behav (1967) 10.59
A model for choice in simple concurrent and concurrent-chains schedules. J Exp Anal Behav (1971) 7.17
Effects of required rates of responding upon choice. J Exp Anal Behav (1968) 6.58
Choice, rate of reinforcement, and the changeover delay. J Exp Anal Behav (1970) 6.24
Choice behavior and the accessibility of the reinforcer. J Exp Anal Behav (1972) 6.14
Choice for periodic schedules of reinforcement. J Exp Anal Behav (1970) 5.56
Secondary reinforcement and number of primary reinforcements. J Exp Anal Behav (1968) 4.59
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood (1995) 4.12
Effects on choice of reinforcement delay and conditioned reinforcement. J Exp Anal Behav (1978) 3.84
Choice: Some quantitative relations. J Exp Anal Behav (1983) 3.21
Relative delay of reinforcement and choice. J Exp Anal Behav (1973) 2.65
The psychological distance to reward. J Exp Anal Behav (1972) 2.59
stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. Mol Biochem Parasitol (1998) 2.58
The delay-reduction hypothesis of conditioned reinforcement and punishment: Observing behavior. J Exp Anal Behav (1981) 2.49
Cognition and behavior analysis: a review of Rachlin's judgment, decision, and choice. J Exp Anal Behav (1990) 2.22
Multiprotein transcription factor UAF interacts with the upstream element of the yeast RNA polymerase I promoter and forms a stable preinitiation complex. Genes Dev (1996) 2.19
Human observing: Maintained by stimuli correlated with reinforcement but not extinction. J Exp Anal Behav (1983) 2.13
Human observing: maintained by negative informative stimuli only if correlated with improvement in response efficiency. J Exp Anal Behav (1985) 2.09
Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. N Engl J Med (1998) 2.05
Choice and foraging. J Exp Anal Behav (1982) 2.02
Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.88
The symmetrical law of effect and the matching relation in choice behavior. J Exp Anal Behav (1978) 1.87
European principles of haemophilia care. Haemophilia (2008) 1.84
Molecular characterization of a carbon transporter in plastids from heterotrophic tissues: the glucose 6-phosphate/phosphate antiporter. Plant Cell (1998) 1.82
"Automaintenance": the role of reinforcement. J Exp Anal Behav (1974) 1.74
Percentage reinforcement and choice. J Exp Anal Behav (1979) 1.72
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood (1997) 1.69
Transitivity as a property of choice. J Exp Anal Behav (1972) 1.68
Behavior analysis and decision making. J Exp Anal Behav (1998) 1.67
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia (2009) 1.61
Editorial. J Exp Anal Behav (1988) 1.61
Observing behavior in a computer game. J Exp Anal Behav (1990) 1.58
Effects of delayed conditioned reinforcement in chain schedules. J Exp Anal Behav (1987) 1.54
Learning to commit or avoid the base-rate error. Nature (1996) 1.54
Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels. Haemophilia (2010) 1.51
Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice. J Thromb Haemost (2008) 1.48
Assessment of ketorolac as an adjuvant to fentanyl patient-controlled epidural analgesia after radical retropubic prostatectomy. Anesthesiology (1993) 1.47
Comparison of standard endoscopic submucosal dissection (ESD) versus an optimized ESD technique for the colon: an animal study. Endoscopy (2009) 1.44
Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia (2010) 1.41
Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up. Haemophilia (2007) 1.40
A case-control study on the psychological aspects and coping in haemophilic patients. Haemophilia (2004) 1.39
[Argon plasma surgery (APC) in the upper aerodigestive tract. Initial results]. HNO (1998) 1.39
Unification of models for choice between delayed reinforcers. J Exp Anal Behav (1990) 1.38
Morphine antagonises action of prostaglandin in neuroblastoma and neuroblastoma times glioma hybrid cells. Nature (1975) 1.38
Construction and characterization of a Plasmodium vivax genomic library in yeast artificial chromosomes. Genomics (1997) 1.34
A molecular analysis of choice on concurrent-chains schedules. J Exp Anal Behav (1987) 1.33
Sequence analysis and protein import studies of an outer chloroplast envelope polypeptide. Proc Natl Acad Sci U S A (1990) 1.33
Some effects of interreinforcement time upon choice. J Exp Anal Behav (1972) 1.31
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost (2008) 1.29
Choice and the relative immediacy of reinforcement. J Exp Anal Behav (1982) 1.28
Expression of the functional mature chloroplast triose phosphate translocator in yeast internal membranes and purification of the histidine-tagged protein by a single metal-affinity chromatography step. Proc Natl Acad Sci U S A (1993) 1.28
Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J Immunol (2000) 1.27
High resolution BrainPET combined with simultaneous MRI. Nuklearmedizin (2011) 1.26
Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26
Second-order schedules: discrimination of components. J Exp Anal Behav (1975) 1.25
Choice and response contingencies. J Exp Anal Behav (1975) 1.18
Conditioned reinforcement value and choice. J Exp Anal Behav (1991) 1.18
An appraisal of preference for multiple versus mixed schedules. J Exp Anal Behav (1974) 1.17
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. Leukemia (2009) 1.16
The 'prespore-like cells' of Dictyostelium have ceased to express a prespore gene: analysis using short-lived beta-galactosidases as reporters. Development (1994) 1.15
Expression of the triose phosphate translocator gene from potato is light dependent and restricted to green tissues. Mol Gen Genet (1993) 1.14
Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in. Leukemia (2012) 1.13
Lifetime occupation, education, smoking, and risk of ALS. Neurology (2007) 1.12
Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int J Oncol (1998) 1.12
Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood (1995) 1.12
Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? Mol Psychiatry (1998) 1.11
Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia (2003) 1.10
Uncertainty reduction, conditioned reinforcement, and observing. J Exp Anal Behav (1980) 1.09
[Subependymal cell proliferation and tumor disposition in brachycephalic dog breeds]. Acta Neuropathol (1967) 1.09
Diagnostics and therapy of lymphoceles after kidney transplantation. Transplant Proc (2006) 1.08
Current status of the Plasmodium falciparum genome project. Mol Biochem Parasitol (1996) 1.08
B-cell deficiency suppresses vaccine-induced protection against murine filariasis but does not increase the recovery rate for primary infection. Infect Immun (2001) 1.08
Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost (2009) 1.07
Clinical severity of haemophilia A: does the classification of the 1950s still stand? Haemophilia (2011) 1.07
Parasitism and chromosome dynamics in protozoan parasites: is there a connection? Mol Biochem Parasitol (1995) 1.07
Choice, foraging, and reinforcer duration. J Exp Anal Behav (1986) 1.06
Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis. Carcinogenesis (2001) 1.06
Risk of inhibitor development in mild haemophilia A increases with age. Haemophilia (2011) 1.05
The effects of component duration on multiple-schedule performance in closed and open economies. J Exp Anal Behav (1988) 1.05
Jaw fractures in the County of Kopparberg and Stockholm 1979-1988. A retrospective comparative study of frequency and cause with special reference to assault. Swed Dent J (1991) 1.05
Choice As A Function Of Reinforcement Ratios In Delayed Matching-to-sample. J Exp Anal Behav (1996) 1.04
Cognition and behavior analysis. J Exp Anal Behav (1989) 1.04
Continuous in vitro propagation and differentiation of cultures of the intramolluscan stages of the human parasite Schistosoma mansoni. Proc Natl Acad Sci U S A (1999) 1.04
Bee venom neurotoxin (apamin): iodine labeling and characterization of binding sites. Eur J Biochem (1979) 1.02
Behavior analysis and behavioral ecology: A synergistic coupling. Behav Anal (1985) 1.02
A study on HIV and hepatitis C virus among commercial sex workers in Tallinn. Sex Transm Infect (2008) 1.02
EUHASS: The European Haemophilia Safety Surveillance system. Thromb Res (2011) 1.02
Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol (2001) 1.02
High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood (1996) 1.01
Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands. Br J Haematol (2005) 1.01
Interleukin-4 is essential for the control of microfilariae in murine infection with the filaria Litomosoides sigmodontis. Infect Immun (2001) 1.00
Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci U S A (1996) 1.00